SVNT. Savient Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting http://finance.yahoo.com/news/savient-announces-multiple-abstracts-related-113000941.html stockcharts.com/c-sc/sc?s=SVNT&p=W&yr=1&mn=0&dy=0&i=t30885261588&r=1348142447315